A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/156, 167/237
A61K 31/415 (2006.01) A61K 9/70 (2006.01)
Patent
CA 1089362
Abstract of the Disclosure Therapeutic system in the form of a skin patch that administers clonidine transdermally in an initial priming dose of 10 to 300 mcg/cm2 of skin that brings the concentration of clonidine in the blood to a level sufficient to elicit alpha-adrenergic stimulation without intolerable side effects, followed by a substantially constant continuous dosage in the range of 0.1 to 100 mcg/hr that maintains said level. The system is a five-layer laminate of, from the top: a protective backing; a gelled, mineral oil- polyisobutene-clonidine reservoir lamina that contains the clonidine that is administered as a continuous constant dosage; a microporous membrane that controls the constant dosage rate; a gelled, mineral oil-polyisobutene- clonidine contact adhesive layer that contains the clonidine that is adminis- tered as a priming dose and the means by which the system is attached to the skin and a strippable coating laminar.
289824
Chandrasekaran Santosh K.
Cleary Gary W.
Darda Siegfried
Michaels Alan S.
Alza Corporation
Boehringer Ingelheim G.m.b.h.
Smart & Biggar
LandOfFree
Therapeutic system for administering clonidine transdermally... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic system for administering clonidine transdermally..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic system for administering clonidine transdermally... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-815285